However, although drugs targeting TLR4 and CBR1 proteins have been developed, such as TLR4 (Papain and Cyclobenzaprine) and CBR1 (Heptaethylene glycol and Haloperidol), no drugs have been found for treating childhood asthma. The gene discussed is CBR1; the disease is asthma.